CONCLUSIONS
The aim of this prognostic assessment tool is the identification of high-risk pregnancies among those with an sFlt-1/PlGF ratio above 38. This prognostic assessment tool includes NT-proBNP, which is a cardiac damage marker that has been identified as a pre-eclampsia prognosis predictor using a study design that allows repeated measurements. In this context, we do not recommend assessing pregnancy prognosis solely using sFlt-1/PlGF ratio raw values as there seems to be better alternatives.